Case Study: Hyperhidrosis Global Phase III

Novella Clinical was asked to conduct a Phase III safety and efficacy study of a treatment for hyperhidrosis (excessive sweating) at sites in the US and Germany. The study required a large patient population in order to meet all the inclusion criteria. Novella’s past experience with hyperhidrosis studies led it to improve collection techniques, and to select sites with experience in hyperhidrosis and gravimetric measurement in order to shorten the study startup time. As a result of Novella’s strategic training approach, dramatically reduced screen failure rates were achieved.